Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in Chinese patients with aplastic anemia refractory or intolerant to cyclosporin A assessing the efficacy and safety of sirolimus with or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin A (cyclosporine)
  • Sirolimus (Sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anaemia | Phase 2 | Status: RECRUITING